Coinbase has recently added two altcoins to its listing roadmap, triggering price rallies for the digital assets of these projects.
The exchange has announced that Bio Protocol (BIO), a biotechnology-focused project, and Euler (EUL), a decentralized finance (DeFi) lending platform, are potential candidates to be made available for trading by Coinbase customers. You can find more information here.
Inclusion in Coinbase’s listing roadmap indicates that the prominent US crypto exchange is contemplating introducing trading support for these assets in the near future. The roadmap was introduced in 2022 to enhance transparency and prevent investors from preempting new trading support announcements.
Following the announcement, BIO is currently trading at $0.06963, reflecting a 9.1% increase in the last 24 hours. However, it has dipped from its peak of $0.07799 during the day.
On the other hand, EUL experienced a recent low of $12.63 before surging to $14.12 post the Coinbase announcement. As of now, EUL has retraced back to the $13 range.
BIO serves as the native token for the Bio Protocol platform, which aims to accelerate biotechnology by enabling global communities of patients, scientists, and biotech professionals to collectively fund, develop, and own tokenized biotech projects and intellectual property.
Meanwhile, EUL acts as the native governance token for the Euler protocol, which seeks to streamline lending and borrowing processes, make them more efficient and versatile, and empower users to explore new opportunities in the DeFi space.
For more updates, follow us on X, Facebook, and Telegram
Stay informed by subscribing to receive email alerts directly in your inbox
Monitor Price Action
Explore The Daily Hodl Mix
Image Credit: Midjourney
